Format

Send to

Choose Destination
See comment in PubMed Commons below
Expert Rev Clin Immunol. 2008 Mar;4(2):143-55. doi: 10.1586/1744666X.4.2.143.

Mometasone furoate monohydrate nasal spray for the treatment of nasal congestion in allergic rhinitis.

Author information

1
Sneeze, Wheeze and Itch Associates, 2010 Jacobssen Drive, Normal, IL 61761, USA. drnayak@asthma2.com

Abstract

Allergic rhinitis (AR) affects an estimated 20-40 million Americans annually. It is a multifaceted condition comprising a range of symptoms, including nasal congestion, arguably the most bothersome symptom. Of the various types of medications available for the treatment of AR, intranasal corticosteroids are considered the most effective. Mometasone furoate nasal spray is an intranasal corticosteroid with anti-inflammatory properties. It is indicated for the treatment of the nasal symptoms of seasonal AR and perennial AR in adults and children, for the prophylaxis of nasal symptoms of seasonal AR and for the treatment of nasal polyps. Numerous clinical trials have demonstrated that mometasone furoate nasal spray effectively relieves nasal congestion in adults and children with AR, while providing excellent safety and tolerability.

PMID:
20477046
DOI:
10.1586/1744666X.4.2.143
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center